Search results for CXCR2 Antibody

Anti-CD182/CXCR2 Antibody (R3G65), AntibodySystem, RHD65006

Anti-CXCR2 antibody [EPR22301-103], Abcam, AB225732

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CXCR2 antibody [MM0222-7J40], Abcam, AB89254

Anti-CXCR2 Antibody (N146/18), AntibodySystem, RHD65004

Anti-CXCR2 Antibody (N146/19), AntibodySystem, RHD65002

Anti-CXCR2 Antibody (N146/23), AntibodySystem, RHD65003

Anti-Human CD182/CXCR2 Antibody (SAA1360), ProteoGenix, ARO-A22956

PE Anti-CXCR2 antibody [EPR22301-103], Abcam, AB318390

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

APC Anti-CXCR2 antibody [EPR22301-103], Abcam, AB318493

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Anti-CXCR2 antibody [HL2604] - BSA and Azide free, Abcam, AB325849